IDEAYA Biosciences Inc (IDYA)
41.53
-0.91
(-2.14%)
USD |
NASDAQ |
May 16, 16:00
41.55
+0.02
(+0.05%)
Pre-Market: 20:00
IDEAYA Biosciences Total Assets (Quarterly): 961.53M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 961.53M |
| December 31, 2023 | 649.32M |
| September 30, 2023 | 532.94M |
| June 30, 2023 | 527.56M |
| March 31, 2023 | 364.75M |
| December 31, 2022 | 387.97M |
| September 30, 2022 | 410.91M |
| June 30, 2022 | 338.01M |
| March 31, 2022 | 358.87M |
| December 31, 2021 | 381.35M |
| September 30, 2021 | 399.44M |
| Date | Value |
|---|---|
| June 30, 2021 | 328.40M |
| March 31, 2021 | 326.10M |
| December 31, 2020 | 298.27M |
| September 30, 2020 | 301.38M |
| June 30, 2020 | 184.51M |
| March 31, 2020 | 101.79M |
| December 31, 2019 | 113.00M |
| September 30, 2019 | 122.33M |
| June 30, 2019 | 133.36M |
| March 31, 2019 | 92.68M |
| December 31, 2018 | 96.54M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
101.79M
Minimum
Mar 2020
961.53M
Maximum
Mar 2024
361.09M
Average
348.44M
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co Inc | 105.85B |
| Pfizer Inc | 221.10B |
| Geron Corp | 482.07M |
| Verastem Inc | 123.54M |
| Karyopharm Therapeutics Inc | 204.46M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.22M |
| Shareholders Equity (Quarterly) | 935.31M |